When an unauthorized party sells a product outside of authorized and/or intended distribution channels, leading to a significant loss of profits for the manufacturer
WEBINAR | June 6th at 10am EST/4pm CET
Pharma supply chain insights to action
with IDC Analysts
Exclusive data-driven session on “Solving the Critical Pharmaceutical Supply Chain Challenges” with the latest research findings on industry trends and innovative technologies to address market needs.